KR102327467B1 - 생선 알레르기의 항원 - Google Patents

생선 알레르기의 항원 Download PDF

Info

Publication number
KR102327467B1
KR102327467B1 KR1020187034023A KR20187034023A KR102327467B1 KR 102327467 B1 KR102327467 B1 KR 102327467B1 KR 1020187034023 A KR1020187034023 A KR 1020187034023A KR 20187034023 A KR20187034023 A KR 20187034023A KR 102327467 B1 KR102327467 B1 KR 102327467B1
Authority
KR
South Korea
Prior art keywords
glu
lys
leu
ala
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187034023A
Other languages
English (en)
Korean (ko)
Other versions
KR20190017755A (ko
Inventor
카요코 마츠나가
아키코 야가미
나오시 시모죠
Original Assignee
호유 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호유 가부시키가이샤 filed Critical 호유 가부시키가이샤
Priority to KR1020217036859A priority Critical patent/KR102464848B1/ko
Publication of KR20190017755A publication Critical patent/KR20190017755A/ko
Application granted granted Critical
Publication of KR102327467B1 publication Critical patent/KR102327467B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
    • A23L17/30—Fish eggs, e.g. caviar; Fish-egg substitutes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/461—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from fish
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/304—Foods, ingredients or supplements having a functional effect on health having a modulation effect on allergy and risk of allergy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
KR1020187034023A 2016-06-16 2017-04-28 생선 알레르기의 항원 Active KR102327467B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020217036859A KR102464848B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2016-119919 2016-06-16
JP2016119919 2016-06-16
PCT/JP2017/017018 WO2017217128A1 (ja) 2016-06-16 2017-04-28 魚アレルギーの抗原

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020217036859A Division KR102464848B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원

Publications (2)

Publication Number Publication Date
KR20190017755A KR20190017755A (ko) 2019-02-20
KR102327467B1 true KR102327467B1 (ko) 2021-11-16

Family

ID=60663992

Family Applications (5)

Application Number Title Priority Date Filing Date
KR1020187034023A Active KR102327467B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원
KR1020217036859A Active KR102464848B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원
KR1020227038525A Active KR102687458B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원
KR1020237041049A Ceased KR20230167444A (ko) 2016-06-16 2017-12-20 알레르기의 항원 및 그 에피토프
KR1020197032672A Ceased KR20200002887A (ko) 2016-06-16 2017-12-20 알레르기의 항원 및 그 에피토프

Family Applications After (4)

Application Number Title Priority Date Filing Date
KR1020217036859A Active KR102464848B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원
KR1020227038525A Active KR102687458B1 (ko) 2016-06-16 2017-04-28 생선 알레르기의 항원
KR1020237041049A Ceased KR20230167444A (ko) 2016-06-16 2017-12-20 알레르기의 항원 및 그 에피토프
KR1020197032672A Ceased KR20200002887A (ko) 2016-06-16 2017-12-20 알레르기의 항원 및 그 에피토프

Country Status (6)

Country Link
US (4) US20190256566A1 (https=)
EP (3) EP3474013A4 (https=)
JP (6) JP6830605B2 (https=)
KR (5) KR102327467B1 (https=)
CN (4) CN109313182B (https=)
WO (2) WO2017217128A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102327467B1 (ko) 2016-06-16 2021-11-16 호유 가부시키가이샤 생선 알레르기의 항원
EP3546946A1 (en) * 2018-03-29 2019-10-02 Rüdiger Lange Method of diagnosing heart muscle damage
CN109503699B (zh) * 2019-01-08 2021-08-31 福建农林大学 一种带鱼鱼肉降血压肽
CN111474281B (zh) * 2020-05-27 2022-08-05 中国检验检疫科学研究院 一种利用特征标识肽段鉴别三文鱼种类的方法
JP7796376B2 (ja) * 2021-03-31 2026-01-09 学校法人藤田学園 牛乳アレルギーの新規抗原
CN116082483B (zh) * 2022-09-09 2024-05-28 大连工业大学 一种具有改善骨质疏松、增强骨密度的多肽制备方法及应用
CN118772238B (zh) * 2024-08-14 2025-05-16 成都大学 免疫调节九肽及应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005063A1 (en) * 1989-10-05 1991-04-18 Exoxemis, Inc. Haloperoxidase acid optimum chemiluminescence assay system
ES2383002T3 (es) * 1998-01-30 2012-06-15 Allertein Therapeutics, Llc Prueba pronóstica de alergia
JP2000125775A (ja) * 1998-10-23 2000-05-09 Nippon Meat Packers Inc 低アレルゲン性ゼラチン
CO5271699A1 (es) * 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
JP4613441B2 (ja) * 2000-04-26 2011-01-19 チッソ株式会社 新規ルシフェラーゼおよび発光蛋白質
US20040161746A1 (en) 2000-12-21 2004-08-19 Yoshiko Matsumoto Method of testing allergic disease
JP4578709B2 (ja) 2001-03-28 2010-11-10 三菱化学メディエンス株式会社 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
JP2002360252A (ja) * 2001-04-27 2002-12-17 Toshiji Suzuki アミロイド前駆体タンパク質代謝分解の阻害因子
JP2004000155A (ja) * 2002-02-28 2004-01-08 Sankyo Co Ltd 心不全の病態予測用マーカーおよびその利用方法
AU2002951411A0 (en) * 2002-09-16 2002-09-26 The University Of Sydney Genotype screen
JP4841494B2 (ja) * 2006-12-11 2011-12-21 株式会社マルハニチロ水産 食品中タンパク質の高感度検出法
WO2009078806A2 (en) 2007-12-19 2009-06-25 Bror Christer Malm Skeletal muscle proteome, muscle function and physical performance
JP2009236809A (ja) * 2008-03-28 2009-10-15 Itea Inc アレルゲン特定用標準アレルゲン及びアレルゲン検出用抗体並びにその利用
CN101492495B (zh) * 2009-02-24 2011-08-31 中国农业科学院哈尔滨兽医研究所 一组抗原表位多肽及其应用
JP5190423B2 (ja) 2009-08-04 2013-04-24 ホーユー株式会社 ２次元電気泳動方法
JP5513802B2 (ja) 2009-08-04 2014-06-04 ホーユー株式会社 等電点電気泳動用ゲル及び等電点電気泳動方法
JP5475358B2 (ja) 2009-08-04 2014-04-16 ホーユー株式会社 ２次元電気泳動方法
JP5433341B2 (ja) 2009-08-04 2014-03-05 ホーユー株式会社 等電点電気泳動方法及び粗雑物除去の判定方法
EP3492922B1 (en) * 2009-09-14 2025-11-05 Icahn School of Medicine at Mount Sinai Methods for characterizing antibody binding affinity and epitope diversity in food allergy
KR101046284B1 (ko) 2009-09-25 2011-07-04 한국건설기술연구원 자연환기식 유니트의 필터 교체구조
KR101123843B1 (ko) 2009-09-25 2012-03-19 홍석희 가시설 구조체의 평형 상태 평가, 조정, 예측 방법 및 그 장치
KR101060752B1 (ko) 2009-09-25 2011-08-30 한국전력공사 나선형 파형관용 이음장치
KR20110033546A (ko) 2009-09-25 2011-03-31 장동원 바스켓이 구비된 저수형 오수받이
US20110243993A1 (en) * 2010-03-29 2011-10-06 Broo Kerstin S Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments
WO2013113325A1 (en) * 2012-01-31 2013-08-08 Curevac Gmbh Negatively charged nucleic acid comprising complexes for immunostimulation
ES3006307T3 (en) * 2013-06-27 2025-03-18 Vitro Flat Glass Llc Glass manufacturing system incorporating an optical low-coherence interferometry assembly
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
CA2935722A1 (en) * 2014-01-21 2015-07-30 Immune Design Corp. Compositions for use in the treatment of allergic conditions
CN103931936B (zh) * 2014-04-09 2015-08-19 长沙学院 一种淡水鱼小清蛋白过敏原抑制剂
JP5894695B1 (ja) * 2015-05-25 2016-03-30 ホーユー株式会社 ウズラの卵アレルギーの抗原
KR102327467B1 (ko) 2016-06-16 2021-11-16 호유 가부시키가이샤 생선 알레르기의 항원

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Cristina Gamez et al, Molecular Nutrition & Food Research (2014.06.30.), vol 58, no 9, pp 1915-1925.
Elsayed S et al, J Allergy (1971.05.), vol 4795), pp 283-291.
Kobayashi Y et al, Allergology International (2016.02.25.), vol 65, no 3, pp 272-279.
Lee Joomin et al, Cell Biochem Funct (2016.05.05.), vol 34, pp 317-325.
Perez-gordo M et al, Int Arch Allergy Immunol (2012), vol 157(1), pp 31-40.
Sakaguchi M et al, J Allergy Clin Immunol (2000.09.), vol 106(3), pp 579-584.
Van Do et al, Journal of Allergy and Clinical Immunology (2005.12.01.), vol 116, no 6, pp 1314-1320.
야스마 카즈마 et al, 식이성 심마진(두드러기)의 알레르기(allergy) 학문적 연구 : (1)사카나에 의하는 알레르기성(allergy) 식이성 심마진(두드러기), 알레르기(allergy), 1984년, vol 33, no 12, pp 1016-1024.

Also Published As

Publication number Publication date
EP3617707A1 (en) 2020-03-04
JP7727288B2 (ja) 2025-08-21
WO2018198430A1 (ja) 2018-11-01
KR20230167444A (ko) 2023-12-08
CN109313182A (zh) 2019-02-05
JP7038386B2 (ja) 2022-03-18
JPWO2018198430A1 (ja) 2020-03-12
JP2021073451A (ja) 2021-05-13
CN110832326A (zh) 2020-02-21
EP3474013A1 (en) 2019-04-24
EP4089105A3 (en) 2023-01-18
EP3617707A4 (en) 2021-06-30
KR20210142010A (ko) 2021-11-23
CN109313182B (zh) 2022-07-01
WO2017217128A1 (ja) 2017-12-21
KR102464848B1 (ko) 2022-11-09
KR102687458B1 (ko) 2024-07-24
US20240109943A1 (en) 2024-04-04
JP2022174056A (ja) 2022-11-22
JP7470934B2 (ja) 2024-04-19
JP2024096735A (ja) 2024-07-17
EP4089105A2 (en) 2022-11-16
US20230295251A1 (en) 2023-09-21
CN115032405A (zh) 2022-09-09
KR20220153678A (ko) 2022-11-18
KR20190017755A (ko) 2019-02-20
CN118146343A (zh) 2024-06-07
JPWO2017217128A1 (ja) 2019-05-09
JP2022081539A (ja) 2022-05-31
US12528845B2 (en) 2026-01-20
KR20200002887A (ko) 2020-01-08
EP3474013A4 (en) 2020-02-26
US20190256566A1 (en) 2019-08-22
US20200268877A1 (en) 2020-08-27
JP7255824B2 (ja) 2023-04-11
JP6830605B2 (ja) 2021-02-17

Similar Documents

Publication Publication Date Title
KR102327467B1 (ko) 생선 알레르기의 항원
CN110799646B (zh) 变态反应的抗原及其表位
KR102423088B1 (ko) 알 알레르기의 항원
KR102102031B1 (ko) 메추리알 알레르기의 항원
KR20220136215A (ko) 우유 알레르기의 신규 항원
KR20210095986A (ko) 알레르기 항원 및 그 에피토프
KR20220165796A (ko) 대두 알레르기의 항원

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20181123

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200204

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210209

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20210810

A107 Divisional application of patent
GRNT Written decision to grant
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20211111

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20211111

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20211111

End annual number: 3

Start annual number: 1

PG1601 Publication of registration